Select Page

2021 Agenda

Spread out over two days full of leading industry innovators and networking opportunities.

MedTech Innovation Forum 2021 Agenda

Thursday, October 28, 2021

7:30 – 8:15 am PST

EXPERIENCE

Networking Breakfast

8:15 – 8:30 am PST

WELCOME

Welcome and Introduction

Bill Carpou, CEO, Octane

8:30 – 9:30 am PST

PANEL

SPACs: A New Solution to Healthcare Funding

James V. (Jim) Mazzo, Executive Chairman, Neurotech, Chief Executive Officer, Avellino Labs, Advisor, Zeiss, Advisor, Bain Consulting, Board Member, Centricity Vision Inc. (Moderator)

Brent Saunders, Executive Chairman, The Beauty Health Company and Former Chairman & CEO, Allergan

Omar Ishrak, Former CEO & Chairman of the Board, Medtronic

Brad Conlan, CEO, Bimini Health

Delilah Panio, Vice President, US Capital Formation, TMX Group

9:30 – 10:00 am PST

EXPERIENCE 

Networking & Exhibits 

9:30 – 11:00 am PST

FAST PITCH 

Fast Pitch Group 1

10:00 – 10:40 am PST

PANEL

Preparing for Tomorrow’s Pandemic Yesterday

How will collaboration accelerate and advance future endeavors? What worked and what didn’t with this pandemic? How will we pivot to ensure more efficient response and success for future pandemics?

Adam Lohr, Life Science Senior Analyst, RSM (Moderator)

Justin Yang, Catalyst Office Director, BARDA

9:30 – 11:00 am PST

FAST PITCH 

Fast Pitch Group 1 (Continued)

10:40 am – 11:20 pm PST

PANEL

FDA Clearance

What’s new at the FDA? What changes occurred over the past year and how have people adjusted? What will stick and what will go back to normal? How does this impact timelines and costs?

Scott Whitcup, Founder & CEO, Akrivista and Whitecap Biosciences (Moderator)

Bruce Albala, PhD, Associate Dean of Innovation and Clinical Trials, Professor of Neurology and Director in the Center for Clinical Research

Mary Edwards, Vice President, Regulatory and Clinical Affairs, Surgical Structural Heart, Edwards Lifesciences

Malvina Eydelman, MD, FDA

Mark Leahey, President, MDMA

11:00 am  – 12:00 pm PST

FAST PITCH 

Fast Pitch Group 2

11:20 am – 12:00 pm PST

PANEL

Precision Medicine

Applications of precision medicine inpatient treatment to optimize efficiency or therapeutic benefit for particular groups of patients. How has genetic and molecular profiling contributed to the success and applications of precision medicine?

Suzzette Arnal, Director, Product Management, Hematopathology and Coagulation, Quest Diagnostics

Joe Boyd, Global Head, Sales & Marketing, Avellino

Michael Howell, CMO, Dermtech

12:00 – 1:00 pm PST

EXPERIENCE

Lunch

1:00 – 1:40 pm PST

PANEL

Establishing Orange County as a Leader in Pediatric MedTech

How can we make Orange County a national leader in pediatric medtech? Join our panel as we discuss strategies to remove barriers to launch a groundswell in pediatric medtech. We’ll be discussing resources, research, pilot projects, and partnership opportunities. Our panel will share strategies to leverage a pediatric pipeline for product development and sales, along with FDA updates, as we explore ways to streamline pediatric device development.

Dr. Taraman, Chief of Neurology, CHOC and Chief Medical Officer, Cognoa (Moderator)

Dr. Terry Sanger, Chief Scientific Officer, CHOC

1:00 pm – 2:30 pm PST

FAST PITCH 

Fast Pitch Group 3

1:40 am – 2:20 pm PST

PANEL

Healthcare AI

How are we creating an end-to-end ecosystem of world-class Healthcare and AI experts that collaborate to solve complex healthcare problems? By establishing, attracting, and retaining the best companies, talent and jobs in SoCal to address Individualized Health and Medical Strategies that transform the way we prevent illness (wellness), treat illness (therapeutics) and coordinate care (efficiency). Additionally, healthsocal.ai will focus on health equity and once formed in SoCal reach both a national and global population.

Ramin Mousavi, CEO, Cathworks (Moderator)

Dr. Anthony Chang, Chief Intelligence and Innovation Officer, CHOC

Bill Carpou, CEO, Octane

Chris Huff, Chief Strategy Officer, Kofax 

1:00 – 2:30 pm PST

FAST PITCH 

Fast Pitch Group 3 (Continued)

2:20 – 2:30 pm PST

EXPERIENCE

Networking & Exhibits

1:00 – 2:30 pm PST

FAST PITCH 

Fast Pitch Group 3 (Continued)

2:30 – 5:00 pm PST

LAUNCHPAD SBDC

LaunchPad SBDC Company Presentations

A highlight of each year’s MedTech Innovation Forum (MTIF) are the presentations by companies who have recently been through the LaunchPad SBDC evaluation process. The LaunchPad presentations are the result of select medical technology companies who have recently been through the LaunchPad evaluation process. It is one of the most highly anticipated   sessions of Octane’s annual MedTech Innovation Forum.

5:00 – 5:15 pm PST

EXPERIENCE

Closing Remarks

Tom Mitro, President & CEO, Aerie Pharmaceuticals 

5:15 – 7:00 pm PST

EXPERIENCE

Networking Cocktail Reception
Friday, October 29, 2021

8:00 – 9:00 am PST

BREAKFAST WITH EXPERTS

Breakfast with Experts Sessions

9:00 – 9:15 pm PST

EXPERIENCE

Networking & Exhibits

9:15 – 9:30 am PST

WELCOME

Welcome and Introduction

Tom Mitro, President & CEO of Aerie Pharmaceuticals

9:30 – 10:15 am PST

KEYNOTE

Fireside Chat with Barry Arbuckle, President & CEO, Memorial Care

Our keynote will address how medical device and other med-tech suppliers need to understand how COVID changed the way that health systems will view the purchase and use of products ranging from implantable devices (heart valves, orthopedic implants, etc.) to diagnostic instruments and down to daily low-tech consumables. It will help med-tech companies understand the right way to approach health systems and the right way to package their offerings to you and your colleagues in the post-COVID ‘new’ world.

Barry Arbuckle, President & CEO, Memorial Care

Clay Wilemon, President & Chief Commercial Officer, APATICS (Interviewer)

10:15 – 10:40 pm PST

EXPERIENCE

Networking & Exhibits

10:40 – 11:20 am PST

PANEL

Innovation in Mental Health

The question is no longer whether technology will transform mental health care, but when and how it will occur. 2020 was an unprecedented year for investment in mental health start-ups. According to Rock Health, the venture capital industry invested $1.8 billion in mental health startups in 2020, a threefold increase over 2019.

Dr. Rick Afable, President & Board Chair, MindOC / BeWell Orange County

Kim Kovacs, President, The Arcview Group

Evan Levine, CEO & Chairman, PsyBio Therapeutics

11:20 am – 12:00 pm PST

PANEL

Advancing Collaboration with Innovative Products, Services, and Partnerships

What are key tools to ensuring success in this new hybrid environment?  How will companies take advantage of the virtual world to improve products, services, and partnerships?  How will companies adjust to flexible work schedules to retain employees? Does it vary by age of company? How are the virtual workforce and virtual services operating successfully?

Maneesh Goyal, COO, Mayo Clinic

Cherie Henket, Sr. Vice President, Global Human Resources, MicroVention

Alyssa Scholz, Principal, Global Healthcare Practice Area Leader, Gensler

12:00 – 1:00 pm PST

LUNCH PANEL

MedTech and Life Science Diversity

How can we best increase the awareness, understanding, and participation of racial and ethnic minorities in the medtech industry? What specific strategies and goals will help us to improve representation in clinical trials, understand different disease states in minority populations, develop solutions to recruit and retain minority physicians, researchers, and other stakeholders in research and product development, and identify unmet needs in advancing research on health issues unique to minorities?

Dr. Stephanie Manson Brown, Vice President, Head of Clinical Development, Aesthetic Medicine, Allergan Aesthetics

Frantz Tiffeau, Senior Director of Diversity, Inclusion and Belonging, Edwards Lifesciences

1:00 – 1:40 pm PST

PANEL

Acceleration in Neuro Intervention in OC

How is Orange County proving to be a leader in the acceleration of Neuro Intervention? What key products are leading the pathway?

Dave Ferrera, CEO, Neurovascular Entrepreneur

Claire Henchcliffe, MD, PhD, Chair of Neurology, UCI School of Medicine

Azadeh Nasibi, Sr. Director, Strategy & Business Development, Brain Therapies, Medtronic

1:40 am – 2:20 pm PST

PANEL

The Changing Landscape of Acquisitions

Consolidation, process changes, and cash advantages in post-pandemic world have altered the landscape of acquisitions. Are these changes continuing through 2022? How do they advance healthcare and accelerate innovation and growth?

2:20 am – 2:30 pm PST

EXPERIENCE

Closing Remarks

2020 Attending Companies

Advekit

Aerie Pharmaceuticals

AESTHETX

Afortiori Development

AIVITA Biomedical, Inc.

Akrivista

Allergan

Ambry Genetics

Anivie Lifesciences

Atacor Medical, Inc.

Avail Medsystems

Avellino Labs

Bain Capital

Baxter International Inc.

Bio-Tech Executive Search

Bioniz Therapeutics

BioQuest, A Diversified Search Company

Blue Ridge Partners

Boustead Securities, LLC

Brado

Broadcom Foundation

Cal State Fullerton

Calgari Economic Development , Life Sciences

Carl Zeiss Meditec, Inc., ZEISS Group

CCRM (Center for Commercialization of Regenerative Medicine)

Celeris Consulting

Chapman University

Charles River Labs

Charting Success

CHOC Children’s Hospital

City of Aliso Viejo

City of Hope

Clinical Trials Ontario

Clinical Trials Ontario, Canada

CLSA

Cognesium Biomed LLC

Consulate General of Canada

Cosmos Health Solutions

Curiato Inc. Waterloo,

Detect Inc.

Dinsmore

Dinsmore Inc.

DxTerity Diagnostics

eDevice

Edwards Lifesciences

Epidarex Capital

Ernst & Young

Excelera Health

Experian

EY

FirstWord Group

FirstWord MedTech

FirstWord Pharma

FivePoint

Flanders Investment and Trade

Fragomen Worldwide

Goddard Inc

Greater Irvine Chamber

Gynesonics

HBA

Healio

HIG Capital

Hoag

ImmunogenX

Insperity

Invest in Grenoble-Alpes France

Invoy Technologies

IRegained Inc.

Jeffrey J. Kimbell & Associates

JK Advisors

Johnson & Johnson

Johnson & Johnson Vision

Jones Lange LaSalle

K&L Gates

KA Imaging Inc

Kapor Capital

Knobbe Martens

LDI Color Toolbox

LilaMax

Lincoln Financial Advisors

LSI

Lumenis

Masimo

Medtronic

Medtronic Diabetes

Medtronic Neurovascular

Medttronic

Memorial Care

Menlo Micro

MicroVention, Inc.

MVM Partners

NEA

Nested Knowledge

NowRx

Omnica Corporation

One Nucleus

Portfolia FemTech Fund I & II

PricewaterhouseCoopers

PricewaterhouseCoopers LLP

Privy

Promedica

PwC

Quest Diagnostics

Recros Medica

Rekovar Inc

Remedy

Renata Medical

ROTH

ROTH Capital Partners

RSM

RSM US LLP

SI02

Slate360

Somnera

Sonex Health, Inc.

Sorrento

StarFish Medical Inc.

Stradling

Stuart Kane LLP

Sullivan & Sampson PR

Syneos Health

Tech Tools Innovation

Teijin Pharma Limited

TMX Group

Toronto Stock Exchange

UC Irvine

UCI Applied Innovation Board, Dartbrook Partners, LLC

UCI Beall Applied Innovation

UCLA/CSUF

University Lab Partners

Unshackled Ventures

USGI Medical, Inc.

Visionary Venture Fund

VIVEX

Wavemaker Three-Sixty Health

Wilson Sonsini

Wilson Sonsini Goodrich & Rosati

ZEISS